IPO registrations (S-1, F-1) · Registrants
Zynerba Pharmaceuticals, Inc.
- SEC CIK
- 1621443 · filings on EDGAR ↗
- Former names
- Zynerba Pharmeceuticals, Inc. (2014–2015)
- Registration
- Form S-1, first filed 2015-06-30, last 2015-07-31; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2015-08-05; declared effective 2015-08-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 80 W. LANCASTER AVENUE, SUITE 300, Devon, PA 19333
- EIN
- 26-0389433
- EDGAR entity type
- operating
- Insiders and CEO pay
- Zynerba Pharmaceuticals, Inc. on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 2015-07-31)
- Final price
- $14.00 per share, within the range (424B4 filed 2015-08-05, an initial public offering)
- Shares sold
- 3,000,000
- Gross proceeds
- $42,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ZYNE
- Lead underwriters
- Jefferies; Piper Sandler
- Syndicate
- Canaccord Genuity; Oppenheimer
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ZYNERBA PHARMACEUTICLAS, INC. EXACT (EIN (EXACT))
- Form D issuer: Zynerba Pharmeceuticals, Inc. EXACT (CIK (EXACT))
- Lobbying client: ZYNERBA PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: ZYNERBA PHARMACEUTICALS, INC. Fuzzy (name and state)
- Lobbying client: ZYNERBA PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: Zynerba Pharmaceuticals, Inc. EXACT (CIK (EXACT))
- Person page: William J Federici Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-30 | S-1 | S-1 (registration) | Zynerba Pharmeceuticals, Inc. | 0001047469-15-005872 ↗ |
| 2015-07-23 | S-1/A | S-1/A (amendment) | Zynerba Pharmaceuticals, Inc. | 0001047469-15-006272 ↗ |
| 2015-07-31 | S-1/A | S-1/A (amendment) | Zynerba Pharmaceuticals, Inc. | 0001047469-15-006467 ↗ |
| 2015-08-04 | EFFECT | EFFECT (declared effective) | Zynerba Pharmaceuticals, Inc. | 9999999995-15-002172 ↗ |
| 2015-08-05 | 424B4 | 424B4 (final prospectus) | Zynerba Pharmaceuticals, Inc. | 0001047469-15-006601 ↗ |
| 2016-09-12 | EFFECT | EFFECT (declared effective) | Zynerba Pharmaceuticals, Inc. | 9999999995-16-005674 ↗ |
| 2017-06-15 | EFFECT | EFFECT (declared effective) | Zynerba Pharmaceuticals, Inc. | 9999999995-17-001537 ↗ |
| 2017-06-22 | EFFECT | EFFECT (declared effective) | Zynerba Pharmaceuticals, Inc. | 9999999995-17-001633 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-07-31 | S-1/A | registration statement | $13.00–$15.00 | 3,000,000 | - | Nasdaq ZYNE | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2015-08-05 | 424B4 | final prospectus | $14.00 | 3,000,000 | $42,000,000 | Nasdaq ZYNE | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ANIDO ARMANDO | Director,Officer | Chairman & CEO; Chairman & Chief Exec Officer; Chairman & Chief Exec. Officer | 18 | 2015–2023 | |
| BARON RICHARD A | Officer | Chief Financial Officer | 3 | 2015 | |
| COOPER WARREN D | Director | 11 | 2015–2023 | ||
| FEDERICI WILLIAM J | Director | 18 | 2015–2023 | person page Fuzzy | |
| Hanlon Suzanne M. | Officer | General Counsel; Sec, General Counsel & VP HR; Sec, VP & General Counsel | 9 | 2015–2021 | |
| HARRISON THOMAS L | Director | 9 | 2015–2018 | ||
| KISNER DANIEL L | Director | 11 | 2015–2023 | ||
| MOCH KENNETH I | Director | 22 | 2015–2023 | ||
| RAPP MICHAEL | TenPercentOwner | 9 | 2015–2018 | ||
| Rask Cynthia Ann | Director | 6 | 2015–2017 | ||
| Sebree Terri B | Officer | President | 15 | 2015–2023 | |
| Fickenscher James E | Officer | Chief Financial Officer | 17 | 2016–2023 | |
| Rosenberger Brian | Officer | VP, Commercial; VP, Commercial & Business Dev. | 13 | 2017–2023 | |
| Butler John P. | Director | 10 | 2018–2023 | ||
| Stephenson Pamela | Director | 8 | 2019–2023 | ||
| Parker Albert P | Officer | Chief Legal Officer | 7 | 2022–2023 | |
| Jones Kenneth T | Officer | See Remarks | 3 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-10-09 | Zynerba Pharmeceuticals, Inc. | Pharmaceuticals | $13,000,000 | $7,309,180 | 30 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | ZYNERBA PHARMACEUTICLAS, INC. | PA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Zynerba Pharmeceuticals, Inc. | PA | Form D private offerings | CIK (EXACT) |
| Lobbying client | ZYNERBA PHARMACEUTICALS | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | ZYNERBA PHARMACEUTICALS, INC. | PA | Federal lobbying (LDA) | name and state |
| Lobbying client | ZYNERBA PHARMACEUTICALS, INC. | PA | Federal lobbying (LDA) | name and state |
| Patent assignee | ZYNERBA PHARMACEUTICALS, INC. | PA | Patents (USPTO) | name and state |
| SEC filer | Zynerba Pharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Zynerba Pharmaceuticals, Inc. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ZYNERBA PHARMACEUTICLAS, INC. | EIN (EXACT) | ||
| Person page | William J Federici | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health